Activation of the Ral and Phosphatidylinositol 3′ Kinase Signaling Pathways by the Ras-Related Protein TC21

REFERENCES

• Aletta, J. M., and L. A. Greene. 1988. Growth cone configuration and advance: a time-lapse study using video-enhanced differential interference contrast microscopy. J. Neurosci. 8:1425–1435.
   PubMedGoogle Scholar
• Barker, K. T., and M. R. Crompton. 1998. Ras-related TC21 is activated by mutation in breast cancer cell line, but infrequently in breast carcinomas in vivo. Br. J. Cancer 78:296–300.
   PubMedGoogle Scholar
• Bos, J. L.. 1997. Ras-like GTPases. Biochim. Biophys. Acta 1333:M19–M31.
   PubMed Web of Science ®Google Scholar
• Carboni, J. M., N. Yan, A. D. Cox, X. R. Bustelo, S. M. Graham, M. J. Lynch, R. Weinmann, B. R. Seizinger, C. J. Der, M. Barbacid, and V. Manne. 1995. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation. Oncogene 10:1905–1913.
   PubMedGoogle Scholar
• Chan, A. M. L., T. Miki, A. M. Kimberly, and S. A. Aaronson. 1994. A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. Proc. Natl. Acad. Sci. USA 91:77558–7562.
   Google Scholar
• Clark, G. J., M. S. Kinch, T. M. Gilmer, K. Burridge, and C. J. Der. 1996. Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. Oncogene 12:169–176.
   PubMedGoogle Scholar
• Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841–852.
   PubMed Web of Science ®Google Scholar
• Cox, A. D., T. R. Brtva, D. G. Lowe, and C. J. Der. 1994. R-Ras induces malignant, but not morphologic transformation of NIH 3T3 cells. Oncogene 9:3281–3288.
   PubMedGoogle Scholar
• Datta, K., A. Bellacosa, T. O. Chan, and P. N. Tsichlis. 1996. Akt is a direct target of the phosphatidylinositol 3-kinase: activation by growth factors, v-Src and v-Ha-Ras, in Sf9 and mammalian cells. J. Biol. Chem. 271:30835–30839.
   PubMed Web of Science ®Google Scholar
• Drivas, G. T., A. Shih, E. Coutavas, M. G. Rush, and P. D'Eutsachio. 1990. Characterization of four novel ras-like genes expressed in a human teratocarcinoma cell line. Mol. Cell. Biol. 10:1793–1798.
   PubMed Web of Science ®Google Scholar
• Dufourny, B., J. Alblas, H. A. van Teeffelen, F. M. van Schaik, B. van der Burg, P. H. Steenbergh, and J. S. Sussenbach. 1997. Mitogenic signalling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J. Biol. Chem. 272:31163–31171.
   PubMed Web of Science ®Google Scholar
• Gille, H., and J. Downward. 1999. Multiple ras effector pathways contribute to G(1) cell cycle progression. J. Biol. Chem. 274:22033–22040.
   PubMed Web of Science ®Google Scholar
• Gioanni, J., D. Le François, E. Zanghellini, C. Mazeau, F. Ettore, J.-C. Lambert, M. Scneider, and B. Dutrillaux. 1990. Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. Br. J. Cancer 62:8–13.
   PubMedGoogle Scholar
• Graham, S. M., A. D. Cox, G. Drivas, M. G. Rush, P. D'Eustachio, and C. J. Der. 1994. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation. Mol. Cell. Biol. 14:4108–4115.
   PubMedGoogle Scholar
• Graham, S. M., S. M. Oldham, C. B. Martin, J. K. Drugan, I. E. Zohn, S. Campbell, and C. J. Der. 1999. TC21 and Ras share indistinguishable transforming and differentiating activities. Oncogene 18:2107–2116.
   PubMedGoogle Scholar
• Guerrero, I., H. Wong, A. Pellicer, and D. E. Burstein. 1986. Activated N-ras gene induces neuronal differentiation of PC12 rat pheochromocytoma cells. J. Cell. Physiol. 129:71–76.
   PubMedGoogle Scholar
• Herrmann, C., G. Horn, M. Spaargaren, and A. Wittinghofer. 1996. Differential interaction of the ras family GTP-binding proteins H-Ras, RaplA, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J. Biol. Chem. 271:6794–6800.
   PubMed Web of Science ®Google Scholar
• Hinoi, T., S. Kishida, S. Koyama, M. Ikeda, Y. Matsuura, and A. Kikuchi. 1996. Posttranslational modifications of Ras and Ral are important for the action of Ral GDP dissociation stimulator. J. Biol. Chem. 271:19710–19716.
   PubMedGoogle Scholar
• Huang, Y., R. Saez, L. Chao, E. Santos, S. A. Aaronson, and A. M.-L. Chan. 1995. A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. Oncogene 11:1255–1260.
   PubMedGoogle Scholar
• Jackson, T. R., I. J. Blader, L. P. Hammondsodie, c. R. Burga, F. Cooke, P. T. Hawkins, A. G. Wolf, K. A. Heldman, and A. B. Theibert. 1996. Initiation and maintenance of NGF-stimulated neurite outgrowth requires activation of a phosphoinositide 3-kinase. J. Cell Sci. 109:289–300.
   PubMedGoogle Scholar
• Kauffman-Zeh, A., P. RodriguezViciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and G. Evan. 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544–548.
   PubMedGoogle Scholar
• Khosravi Far, R., M. A. White, J. K. Westwick, P. A. Solski, M. Chrzanowska Wodnicka, L. Van Aeist, M. H. Wigler, and C. J. Der. 1996. Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation. Mol. Cell. Biol. 16:3923–3933.
   PubMedGoogle Scholar
• Khwaja, A., P. RodriguezViciana, S. Wennstrom, P. H. Warne, and J. Downward. 1997. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 16:2783–2793.
   PubMed Web of Science ®Google Scholar
• Kimmelman, A., T. Tolkacheva, M. V. Lorenzi, M. Osada, and A. M. L. Chan. 1997. Identification and characterization of R-ras3: a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution. Oncogene 15:2675–2685.
   PubMed Web of Science ®Google Scholar
• Kimmelman, A. C., M. Osada, and A. M. Chan. 2000. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells. Oncogene 19:2014–2022.
   PubMedGoogle Scholar
• Kishida, S., S. Koyama, K. Matsubara, M. Kishida, Y. Matsuura, and A. Kikuchi. 1997. Colocalization of Ras and Ral on the membrane is required for Ras-dependent Ral activation through Ral GDP dissociation stimulator. Oncogene 15:2899–2907.
   PubMed Web of Science ®Google Scholar
• Kotani, K., K. Yonezawa, K. Hara, H. Ueda, Y. Kitamura, H. Sakaue, A. Ando, A. Chavanieu, B. Calas, F. Grigorescu, et al.. 1994. Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling. EMBO J. 13:2313–2321.
   PubMedGoogle Scholar
• Lopez Barahona, M., X. Bustelo, and M. Barbacid. 1996. The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor. Oncogene 12:463–470.
   PubMedGoogle Scholar
• Marte, B. M., P. RodriguezViciana, S. Wennstrom, P. H. Warne, and J. Downward. 1997. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr. Biol. 7:63–70.
   PubMed Web of Science ®Google Scholar
• Miller, M. J., S. Prigent, E. Kupperman, L. Rioux, S. H. Park, J. R. Feramisco, M. A. White, J. L. Rutkowski, and J. L. Meinkoth. 1997. RalGDS functions in Ras- and cAMP-mediated growth stimulation. J. Biol. Chem. 272:5600–5605.
   PubMedGoogle Scholar
• Movilla, N., P. Crespo, and X. R. Bustelo. 1999. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins. Oncogene 18:5860–5869.
   PubMedGoogle Scholar
• Nobes, C. D., P. Hawkins, L. Stephens, and A. Hall. 1995. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J. Cell Sci. 108:225–233.
   PubMed Web of Science ®Google Scholar
• Quilliam, L. A., A. F. Castro, K. S. Rogers-Graham, C. B. Martin, C. J. Der, and C. Bi. 1999. M-Ras/R-Ras3, a transforming ras protein regulated by Sos1, GRF1, and p120 Ras GTPase-activating protein, interacts with the putative Ras effector AF6. J. Biol. Chem. 274:23850–23857.
   PubMed Web of Science ®Google Scholar
• Reif, K., C. D. Nobes, G. Thomas, A. Hall, and D. A. Cantrell. 1996. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr. Biol. 6:1445–1455.
   PubMedGoogle Scholar
• Rey, I., P. Taylor-Harris, H. van Erp, and A. Hall. 1994. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation. Oncogene 9:685–692.
   PubMedGoogle Scholar
• RodriguezViciana, P., P. H. Warne, R. Dhand, B. Vanhaesebroeck, I. Gout, M. Fry, M. D. Waterfield, and J. Downward. 1994. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370:527–532.
   PubMedGoogle Scholar
• RodriguezViciana, P., P. H. Warne, A. Khwaja, B. M. Marte, D. Pappin, P. Das, M. D. Waterfield, A. Ridley, and J. Downward. 1997. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89:457–467.
   PubMedGoogle Scholar
• RodriguezViciana, P., P. H. Warne, B. Vanhaesebroeck, M. D. Waterfield, and J. Downward. 1996. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 15:2442–2451.
   PubMedGoogle Scholar
• Rosário, M., H. F. Paterson, and C. J. Marshall. 1999. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. EMBO J. 18:1270–1279.
   PubMedGoogle Scholar
• Rubio, I., P. RodriguezViciana, J. Downward, and R. Wetzker. 1997. Interaction of Ras with phosphoinositide 3-kinase gamma. Biochem. J. 326:891–895.
   PubMedGoogle Scholar
• Spaargaren, M., and J. R. Bischof. 1994. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras and Rap. Proc. Natl. Acad. Sci. USA 91:12609–12613.
   PubMed Web of Science ®Google Scholar
• Stacey, D. W., S. R. De Gudicibus, and M. R. Smith. 1987. Cellular ras activity and tumor cell proliferation. Exp. Cell Res. 171:232–242.
   PubMedGoogle Scholar
• Urano, T., R. Emkey, and L. A. Feig. 1996. Ral-GTPases mediate a distinct downstream signalling pathway from Ras that facilitates cellular transformation. EMBO J. 15:810–816.
   PubMed Web of Science ®Google Scholar
• Walker, E. H., O. Perisic, C. Ried, L. Stephens, and R. L. Williams. 1999. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature 402:313–320.
   PubMed Web of Science ®Google Scholar
• Watton, S. J., and J. Downward. 1999. Akt/PKB localisation and 3′ phosphoinositide generation at sites of epithelial cell-matrix and cell-cell interaction. Curr. Biol. 9:433–436.
   PubMed Web of Science ®Google Scholar
• Wennstrom, S., P. Hawkins, F. Cooke, K. Hara, K. Yonezawa, M. Kasuga, T. Jackson, L. Claesson Welsh, and L. Stephens. 1994. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr. Biol. 4:385–393.
   PubMed Web of Science ®Google Scholar
• White, M. A., C. Nicolette, A. Minden, A. Polverino, L. Van Aelst, M. Karin, and M. Wigler. 1995. Multiple ras functions can contribute to mammalian cell transformation. Cell 80:533–541.
   PubMed Web of Science ®Google Scholar
• White, M. A., T. Vale, J. H. Camonis, E. Schaefer, and M. H. Wigler. 1996. A role for the Ral guanine-nucleotide dissociation stimulator in mediating Ras-induced transformation. J. Biol. Chem. 271:16439–16442.
   PubMed Web of Science ®Google Scholar
• Wolthuis, R. M., B. Bauer, L. J. van't Veer, A. M. de Vries Smits, R. H. Cool, M. Spaargaren, A. Wittinghofer, B. M. Burgering, and J. L. Bos. 1996. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein. Oncogene 13:353–362.
   PubMedGoogle Scholar
• Wolthuis, R. M., N. D. de Ruiter, R. H. Cool, and J. L. Bos. 1997. Stimulation of gene induction and cell growth by the Ras effector Rlf. EMBO J. 16:6748–6761.
   PubMed Web of Science ®Google Scholar
• Wolthuis, R. M., B. Franke, M. van Triest, B. Bauer, R. H. Cool, J. H. Camonis, J. W. Akkerman, and J. L. Bos. 1998. Activation of the small GTPase Ral in platelets. Mol. Cell. Biol. 18:2486–2491.
   PubMed Web of Science ®Google Scholar
• Yao, R. J., and G. M. Cooper. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003–2006.
   PubMed Web of Science ®Google Scholar